Medicine
fromLondon Business News | Londonlovesbusiness.com
1 day agoArmistice Capital increases bicycle therapeutics stake as company awaits regulatory feedback on lead drug candidate - London Business News | Londonlovesbusiness.com
Bicycle Therapeutics advanced zelenectide pevedotin development while investors increased positions ahead of upcoming regulatory feedback and pivotal trial readouts.